Case report: ZEB1 expression in three cases of hepatic carcinosarcoma
Hepatic carcinosarcoma (HCS) is defined as a tumor that contains cancer from the epithelium and sarcoma from mesenchymal tissue. HCS has a low incidence rate and is composed of osteosarcoma, chondrosarcoma, or angiosarcoma. Though surgery is the main treatment for HCS, it has proven unsatisfactory,...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-09-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.972650/full |
| _version_ | 1818065451159126016 |
|---|---|
| author | Mingming Zhang Mingming Zhang Dongchang Yang Lu Li Lu Li Lin Liu Ting Wang Tao Liu Lei Li Yanrong Liu |
| author_facet | Mingming Zhang Mingming Zhang Dongchang Yang Lu Li Lu Li Lin Liu Ting Wang Tao Liu Lei Li Yanrong Liu |
| author_sort | Mingming Zhang |
| collection | DOAJ |
| description | Hepatic carcinosarcoma (HCS) is defined as a tumor that contains cancer from the epithelium and sarcoma from mesenchymal tissue. HCS has a low incidence rate and is composed of osteosarcoma, chondrosarcoma, or angiosarcoma. Though surgery is the main treatment for HCS, it has proven unsatisfactory, resulting in a very poor prognosis of HCS. Currently, the reports on HCS are mainly about the description of clinical pathological phenomena, imaging features, and mutation sites of related genes, the underlying molecular mechanism of HCS remains undefined. Through the dynamic process of epithelial-mesenchymal transition (EMT), cancer cells acquire a mesenchymal phenotype, simultaneously losing epithelial properties. Zinc finger E-box binding homeobox 1 (ZEB1) is an EMT-inducing transcription factor; its main regulatory target is E-cadherin in EMT process. Esophageal carcinosarcoma (ECS) is associated with EMT. The current study showed that EMT might promote the development of ECS and uterine carcinosarcoma (UCS), and ZEB1 was highly expressed in the sarcomatous components. In the current study, three cases were collected, and the clinicopathological features were compared with those of corresponding cases. The expression level, and subcellular localization of ZEB1 were detected using immunohistochemistry. The expression of the ZEB1 in the nucleus was found to be significantly higher in sarcomatous components than that in cancer components in all three cases, suggesting an association of HCS with EMT. |
| first_indexed | 2024-12-10T14:52:06Z |
| format | Article |
| id | doaj.art-16037833cc3e4d8daae2e1344ac52496 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-10T14:52:06Z |
| publishDate | 2022-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-16037833cc3e4d8daae2e1344ac524962022-12-22T01:44:24ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-09-011210.3389/fonc.2022.972650972650Case report: ZEB1 expression in three cases of hepatic carcinosarcomaMingming Zhang0Mingming Zhang1Dongchang Yang2Lu Li3Lu Li4Lin Liu5Ting Wang6Tao Liu7Lei Li8Yanrong Liu9Department of Pathology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaSchool of Clinical Medicine, Jining Medical University, Jining, ChinaDepartment of Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaSchool of Clinical Medicine, Jining Medical University, Jining, ChinaHealth Management Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaDepartment of Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, ChinaHepatic carcinosarcoma (HCS) is defined as a tumor that contains cancer from the epithelium and sarcoma from mesenchymal tissue. HCS has a low incidence rate and is composed of osteosarcoma, chondrosarcoma, or angiosarcoma. Though surgery is the main treatment for HCS, it has proven unsatisfactory, resulting in a very poor prognosis of HCS. Currently, the reports on HCS are mainly about the description of clinical pathological phenomena, imaging features, and mutation sites of related genes, the underlying molecular mechanism of HCS remains undefined. Through the dynamic process of epithelial-mesenchymal transition (EMT), cancer cells acquire a mesenchymal phenotype, simultaneously losing epithelial properties. Zinc finger E-box binding homeobox 1 (ZEB1) is an EMT-inducing transcription factor; its main regulatory target is E-cadherin in EMT process. Esophageal carcinosarcoma (ECS) is associated with EMT. The current study showed that EMT might promote the development of ECS and uterine carcinosarcoma (UCS), and ZEB1 was highly expressed in the sarcomatous components. In the current study, three cases were collected, and the clinicopathological features were compared with those of corresponding cases. The expression level, and subcellular localization of ZEB1 were detected using immunohistochemistry. The expression of the ZEB1 in the nucleus was found to be significantly higher in sarcomatous components than that in cancer components in all three cases, suggesting an association of HCS with EMT.https://www.frontiersin.org/articles/10.3389/fonc.2022.972650/fullhepatic carcinosarcomaEMTZEB1livercarcinosarcoma |
| spellingShingle | Mingming Zhang Mingming Zhang Dongchang Yang Lu Li Lu Li Lin Liu Ting Wang Tao Liu Lei Li Yanrong Liu Case report: ZEB1 expression in three cases of hepatic carcinosarcoma Frontiers in Oncology hepatic carcinosarcoma EMT ZEB1 liver carcinosarcoma |
| title | Case report: ZEB1 expression in three cases of hepatic carcinosarcoma |
| title_full | Case report: ZEB1 expression in three cases of hepatic carcinosarcoma |
| title_fullStr | Case report: ZEB1 expression in three cases of hepatic carcinosarcoma |
| title_full_unstemmed | Case report: ZEB1 expression in three cases of hepatic carcinosarcoma |
| title_short | Case report: ZEB1 expression in three cases of hepatic carcinosarcoma |
| title_sort | case report zeb1 expression in three cases of hepatic carcinosarcoma |
| topic | hepatic carcinosarcoma EMT ZEB1 liver carcinosarcoma |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.972650/full |
| work_keys_str_mv | AT mingmingzhang casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT mingmingzhang casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT dongchangyang casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT luli casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT luli casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT linliu casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT tingwang casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT taoliu casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT leili casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma AT yanrongliu casereportzeb1expressioninthreecasesofhepaticcarcinosarcoma |